Impact of sitagliptin on carotid intima-media thickness in patients with coronary artery disease and impaired glucose tolerance or mild diabetes mellitus

American Journal of Cardiology

Volumn 114, Issue 3, 2014, Pages 384-388

  Ishikawa, Shinji ^a,b   Shimano, Masayuki ^a,c   Watarai, Masato ^b   Koyasu, Masayoshi ^b   Uchikawa, Tomohiro ^b   Ishii, Hideki ^a   Inden, Yasuya ^a   Takemoto, Kenji ^b   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ANJO KOSEI HOSPITAL   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SITAGLIPTIN;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET THERAPY; DRUG EFFECT; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CAROTID ARTERIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRAZINES; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES; TUNICA INTIMA;

EID: 84904259820     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.04.050     Document Type: Article

References (24)

1. B. Gallwitz Review of sitagliptin phosphate: a novel treatment for type 2 diabetes Vasc Health Risk Manag 3 2007 203 210
2. W.E. Schmidt, E.G. Siegel, and W. Creutzfeldt Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets Diabetologia 28 1985 704 707
3. J. Matsubara, S. Sugiyama, K. Sugamura, T. Nakamura, Y. Fujiwara, E. Akiyama, H. Kurokawa, T. Nozaki, K. Ohba, M. Konishi, H. Maeda, Y. Izumiya, K. Kaikita, H. Sumida, H. Jinnouchi, K. Matsui, S. Kim-Mitsuyama, M. Takeya, and H. Ogawa A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice J Am Coll Cardiol 59 2012 265 276
4. L. Liu, J. Liu, W.T. Wong, X.Y. Tian, C.W. Lau, Y.X. Wang, G. Xu, Y. Pu, Z. Zhu, A. Xu, K.S. Lam, Z.Y. Chen, C.F. Ng, X. Yao, and Y. Huang Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism Hypertension 60 2012 833 841
5. N. Satoh-Asahara, Y. Sasaki, H. Wada, M. Tochiya, A. Iguchi, R. Nakagawachi, S. Odori, S. Kono, K. Hasegawa, and A. Shimatsu A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients Metabolism 62 2013 347 351
6. J. Matsubara, S. Sugiyama, E. Akiyama, S. Iwashita, H. Kurokawa, K. Ohba, H. Maeda, K. Fujisue, E. Yamamoto, K. Kaikita, S. Hokimoto, H. Jinnouchi, and H. Ogawa Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes Circ J 77 2013 1337 1344
7. M.L. Bots, P.G. Mulder, A. Hofman, G.A. van Es, and D.E. Grobbee Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study J Clin Epidemiol 47 1994 921 930
8. T.J. Smilde, H. Wollersheim, H. Van Langen, and A.F. Stalenhoef Reproducibility of ultrasonographic measurements of different carotid and femoral artery segments in healthy subjects and in patients with increased intima-media thickness Clin Sci (Lond) 93 1997 317 324
9. D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, and S.K. Wolfson Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 1999 14 22
10. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
11. M. Koyasu, H. Ishii, M. Watarai, K. Takemoto, Y. Inden, K. Takeshita, T. Amano, D. Yoshikawa, T. Matsubara, and T. Murohara Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: a one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease Clin Ther 32 2010 1610 1617
12. Y. Uemura, M. Watarai, H. Ishii, M. Koyasu, K. Takemoto, D. Yoshikawa, R. Shibata, T. Matsubara, and T. Murohara Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease J Cardiol 59 2012 50 56
13. Z. Shah, T. Kampfrath, J.A. Deiuliis, J. Zhong, C. Pineda, Z. Ying, X. Xu, B. Lu, S. Moffatt-Bruce, R. Durairaj, Q. Sun, G. Mihai, A. Maiseyeu, and S. Rajagopalan Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis Circulation 124 2011 2338 2349
14. T. Shigeta, M. Aoyama, Y.K. Bando, A. Monji, T. Mitsui, M. Takatsu, X.W. Cheng, T. Okumura, A. Hirashiki, K. Nagata, and T. Murohara Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions Circulation 126 2012 1838 1851
15. I. Jialal, and M. Bajaj DPP-4 inhibitors and atherosclerosis: the promise Atherosclerosis 227 2013 224 225
16. M. Hanefeld, J.L. Chiasson, C. Koehler, E. Henkel, F. Schaper, and T. Temelkova-Kurktschiev Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance Stroke 35 2004 1073 1078
17. T. Mazzone, P.M. Meyer, S.B. Feinstein, M.H. Davidson, G.T. Kondos, R.B. D'Agostino Sr., A. Perez, J.C. Provost, and S.M. Haffner Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial JAMA 296 2006 2572 2581
18. N. Ervinna, T. Mita, E. Yasunari, K. Azuma, R. Tanaka, S. Fujimura, D. Sukmawati, T. Nomiyama, A. Kanazawa, R. Kawamori, Y. Fujitani, and H. Watada Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice Endocrinology 154 2013 1260 1270
19. T. Murohara Dipeptidyl peptidase-4 inhibitor: another player for cardiovascular protection J Am Coll Cardiol 59 2012 277 279
20. A. Ceriello, C. Taboga, L. Tonutti, R. Giacomello, L. Stel, E. Motz, and M. Pirisi Post-meal coagulation activation in diabetes mellitus: the effect of acarbose Diabetologia 39 1996 469 473
21. H. Kawano, T. Motoyama, O. Hirashima, N. Hirai, Y. Miyao, T. Sakamoto, K. Kugiyama, H. Ogawa, and H. Yasue Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery J Am Coll Cardiol 34 1999 146 154
22. K. Matsumoto, Y. Sera, Y. Abe, T. Tominaga, Y. Yeki, and S. Miyake Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes Diabetes Res Clin Pract 64 2004 225 228
23. Y. Yamasaki, N. Katakami, R. Hayaishi-Okano, M. Matsuhisa, Y. Kajimoto, K. Kosugi, M. Hatano, and M. Hori Alpha-glucosidase inhibitor reduces the progression of carotid intima-media thickness Diabetes Res Clin Pract 67 2005 204 210
24. J.L. Fleg, M. Mete, B.V. Howard, J.G. Umans, M.J. Roman, R.E. Ratner, A. Silverman, J.M. Galloway, J.A. Henderson, M.R. Weir, C. Wilson, M. Stylianou, and W.J. Howard Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial J Am Coll Cardiol 52 2008 2198 2205